Stocks and Investing
Stocks and Investing
Thu, March 2, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Maintained (AXSM) at Strong Buy with Decreased Target to $84 on, Mar 1st, 2023
Graig Suvannavejh of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $86 to $84 on, Mar 1st, 2023.
Graig has made no other calls on AXSM in the last 4 months.
There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 2 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $85 on, Tuesday, February 28th, 2023
- David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023
These are the ratings of the 6 analyists that currently disagree with Graig
- Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, February 28th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $210 on, Tuesday, February 14th, 2023
- Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
- Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022
- Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
Contributing Sources